Innate Pharma S.A. | Ownership
Companies that own Innate Pharma S.A.
Wellington Management Co. LLP
3,471,789
6.03%
764,871
0%
03/06/2018
Perceptive Advisors LLC
2,615,134
4.54%
0
0.33%
03/06/2018
OppenheimerFunds, Inc.
1,000,000
1.74%
0
0%
03/31/2018
HSBC Global Asset Management (France) SA
436,898
0.76%
-17,630
0.03%
12/29/2017
OFI Asset Management SA
380,577
0.66%
0
0.04%
05/31/2018
Schroder Investment Management Ltd.
341,522
0.59%
0
0%
06/30/2018
Tekla Capital Management LLC
300,000
0.52%
0
0.06%
03/31/2018
Norges Bank Investment Management
249,139
0.43%
-249,174
0%
12/31/2017
BlackRock Fund Advisors
234,321
0.41%
418
0%
09/06/2018
Aviva Investors France SA
165,338
0.28%
0
0.02%
08/31/2018
| Address |
117, Avenue de Luminy
Marseille Provence-Alpes-Cote-dAzur 13009
France
|
|
Employees
|
- |
| Website |
http://www.innate-pharma.com/en |
| Updated |
07/08/2019 |
| Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. |
